Patient health care data is the answer to cure the deadliest cancer, this app helps them to share that data securely
Cancer is one of the greatest unsolved medical mysteries of our time. Successes in personalized medicine and big steps in prevention may suggest that we are moving in the right direction, but the numbers say otherwise. The International Agency for Research on Cancer has predicted that by 2040, cancer cases in United Nations countries could increase by 47 percent from 2020. With the incidence of cancer increasing globally, we need to ask ourselves what can be done to reduce it. Unnecessary deaths caused by this complex group of diseases.
For a disease with more than 200 types and subtypes, the answer was never going to be simple. But billions of euros are spent on cancer research every year, opening up new avenues for research into different cancer types and stages. Over the past ten years, the number of oncological tests being initiated per year has increased by 60 percent, from 2,500 in 2007 to nearly 4,000 in 2017. National Institutes of Health. However, for oncology treatments tested in clinical trials, the chance of success is only 5 percent – meaning the real impact of this research on the progress of medical options for patients is minimal.
A necessary change from traditional R&D
It calls for change in cancer research. The traditional process of research and development (R&D) has fatal flaws. For example, when generating hypotheses, researchers manually scour through thousands of papers to identify new molecules or combinations. Furthermore, due to the number of clinical trials, which are never published, the availability of data is poor. Insights from failed trials often do not reach researchers, creating inefficiencies by repeating the same mistakes.
New ways of doing this research include using AI. a company, inoplexus, uses AI to search terabytes of data from the world of published and unpublished research, filters it for reliable sources related to the life sciences, and organizes it for researchers. Thus, the process of hypothesis formulation for clinical trials is accelerated.
However, AI alone is not always enough. Despite offering a major advantage over classical research and development, there are research gaps that only real-world data (RWD) can fill. The RWD comes directly from patients, which is commonly used to review the after-market safety and efficacy of treatments. However, by integrating RWD at different stages in the clinical trial process, we can significantly accelerate and improve the chances of success of treatments from the outset.
How do we collect this data? Did people with cancer not have enough hospital visits and scans? OncoCoin. by CURIA Getting ready to answer these questions to make the collection of RWD easier for patients and researchers to advance cancer research.
Revolutionizing Patient Participation
The CURIA App aims to create a new world of possibilities for patient participation and research. At its core it is designed to provide critical information to help patients manage their disease and make important decisions about their treatment journey. Patients also have access to services like a second opinion, the ability to be matched with the most similar patient in the app to share experiences, and other in-app offerings.
Now comes how this patient ecosystem can revolutionize cancer research. Researchers can submit studies, surveys or questionnaires to the app, which patients can choose to participate in. The information collected may include blood reports, pathology reports, doctor’s letters, or researchers may ask more qualitative questions – for example, regarding quality of life. Data shared by patients is securely licensed to researchers on a blockchain, meaning patients are always in control. In addition, patients are rewarded for their contributions with Oncocoin tokens, which increase in value as the value of the data increases.
Projects like this empower patients to own their own data and become more involved in their cancer journey. statistics Show that patients who feel empowered during their cancer journey report a better standard of care and have also been shown to have improved clinical outcomes. With more empowered patients who take control of their cancer journey, and participate in clinical research, the cancer status quo has a positive future.
AI and Blockchain are unlikely to completely disrupt the healthcare sector without patients working in parallel. The more we can do to make technologies more accessible to patients, giving them hope to change the course of their cancer journey while contributing to cancer research, we will come closer to a cure for this deadly disease.
Click Here To learn more about Oncocoin and the new revolution to transform cancer research.
basically . Published on business reporter
Credit: www.independent.co.uk /